Information, deadlines and resource documents for U.S. trade and tariff actions and the responses by the rest of the world.
Internationally recognized trade compliance training.
1 CCS Credit
Biopharma and life sciences companies face unique challenges when valuing their research and development, clinical, commercial, and compassionate use products for cross-border transactions. These valuation decisions must comply with U.S. customs and tax laws, while complementing the company’s business and tax strategies. Every day, these companies enter into development and supply agreements, license technologies, sign royalty agreements, and source necessary materials to create innovative therapies. What often complicates these transactions is whether their value or cost must be added to the declared value of imported materials.
Contact webinarorganizers@strtrade.com if you have issues registering. Please note we do not take American Express.
This webinar provides an overview of basic U.S. customs law valuation principles and highlights specific areas for review relevant to the industry. This webinar will cover the following topics as it relates to the biopharma and life sciences industry:
Please note we do not accept payment via American Express.
ANDREA K. JEGLUM is an associate for Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. Prior to joining ST&R Ms. Jeglum served for more than 15 years leading global pharmaceutical and biotechnology companies through the complexities of global trade and related regulatory compliance matters.
We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.